Phase solubility analysis in studying the interaction of nifedipine with selected cyclodextrins in aqueous solution

Journal of Inclusion Phenomena and Molecular Recognition in Chemistry

Volumn 25, Issue 1-3, 1996, Pages 153-156

  Worthington, M S ^a   Glass, B D ^a   Penkler, L J ^b  

^a RHODES UNIVERSITY   (South Africa)

^b Druggists Group Research   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030351979     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01041558     Document Type: Article

References (14)

1. Mielcarek, J., Grodzka, J., Inclusion compounds of nifedipine and other 1,4-dihydropyridine derivatives with cyclodextrins I. Complexation of nifedipine with β-cyclodextrin, Acta Pol. Pharm., 51, 15-20 (1994)
2. Nozawa, Y., Yamamoto, A., Effects of roll mixing with β-cyclodextrin on enhancing solubilities of water insoluble drugs, Pharm. Acta Helv., 64, 24-29 (1989)
3. Acatürk, F., Kişjal, Ö., Çelebi, N., The effect of some natural polymers on the solubility and dissolution characteristics of nifedipine. Int. J. Pharm., 85, 1-6 (1992)
4. Uekama, K., Ikegami, K., Wang, Z., Horiuchi, Y., Hirayama, F., Inhibitory effect of 2-hydroxypropyl-β-cyclodextrin on crystal-growth of nifedipine during storage: Superior dissolution and oral bioavailability compared with polyvinylpyrrolidone K-30, J. Pharm. Pharmacol., 44, 73-78 (1992)
5. Yamamoto, M.., Yoshida, A., Hirayama, F., Uekama, K., Some physicochemical properties of β-cyclodextrins and their inclusion characteristics, Int. J. Pharm., 49, 163-171 (1989)
6. Suzuki, H., Uede, H., Kobayashi, S., Nagai, T., Panosyl-β-cyclodextrin and its solubilization ability for poorly water soluble drugs, Eur. J. Pharm. Sci., 1, 159-164 (1993)
7. Higuchi, T., Connors, K.A., Phase-solubility techniques, Adv. Anal. Inst., 4, 117-212 (1965)
8. Higuchi, T., Kristiansen, H., J., Binding specificity between small organic solutes in aqueous solution: Classification of some solutes into two groups according to binding tendencies, Pharm. Sci., 59, 1601-1608 (1970)
9. Uekama, K., Pharmaceutical applications of methylated cyclodextrins, Pharm. Int., 6, 61-65 (1985)
10. Szejtli, J., Cyclodextrins in drug formulations, Pharm. Technol., 15, 36-44 (1991)
11. Green, A.R., Guillory, J.K., Heptakis(2,6-di-O-methyl)-β-cyclodextrin complexation with the antitumor agent chlorambucil, J. Pharm. Sci., 78, 427-431 (1989)
12. Szejtli, J., Cyclodextrins and their inclusion complexes, Akadémia Kiado, Budapest, 1982
13. El-Gendy, G.A., El-Gendy, M.A., Heptakis (2,6-di-O-methyl)-β-cyclodextrin complexation, with glutethimide, Eur. J. Pharm. Biopharm., 39, 249-254 (1993)
14. Haskins, N.J., Saunders, M.R., Camilleri, P., The complexation and chiral selectivity of 2-hydroxypropyl-β-cyclodextrin with guest molecules as studied by electrospray mass spectrometry, Rapid Commun. Mass Spectrom.,8, 423-426 (1994)